Chamanlal Setia Exports Ltd
Q3 FY25 Earnings Call Analysis
Agricultural Food & other Products
fundraise: No informationcapex: Yesrevenue: Category 4margin: Category 2orderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- There is no explicit mention of any current or future fundraising plans through debt or equity during the Q2 & H1 FY26 earnings call.
- The management discusses capacity expansions and increased procurement but does not indicate any specific need for fresh capital raising.
- The company mentions being "cash rich" and having the financial strength to hold inventory without distress.
- Rajeev Setia alludes to capital expenditure for new plants due to demand but does not mention fund-raising activity.
- No direct references to plans for debt or equity issuance to investors or in the Q&A sessions are observed.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- The company has recently added three new SORTEX plants located in Karnal and Mundra as part of its capacity expansion.
- These expansions indicate investment in increasing processing capacity, enabling handling of 25 to 30 container movements daily.
- Rajeev Setia mentioned that with these new plants, the company has a revenue potential of up to INR 2,000 crore, though conservatively targeting INR 1,500 crore for now.
- While exact future capital expenditure figures are not disclosed, there is a clear strategic focus on capacity growth to meet rising demand.
- The management emphasized focusing on profitability and cautiously expanding operational scale aligned with market demand.
- No explicit mention of other specific upcoming strategic or capital investments was made during the call.
📊revenue
Future growth expectations in sales/revenue/volumes?
- The company targets to achieve revenue of INR 1,500 crore in FY26, consistent with past levels.
- New capacities (three SORTEX plants in Karnal and one in Mundra) support potential to reach INR 2,000 crore in revenue if demand grows.
- Current capacity supports 25 to 30 container movements per day.
- Management is cautious yet confident about improving sales and margins in H2 FY26 due to good procurement prices and increasing orders.
- Discussions with Saudi clients and orders from countries where revenue/volume had fallen bolster confidence in hitting revenue targets.
- Global price declines are viewed as buying opportunities; customers are timing purchases anticipating price bottoms.
- Long-term growth potential exists with product promotion and expanding export markets, aiming to regain and exceed past performance.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company is confident of achieving INR 1,500 crore revenue for FY26, indicating stable growth.
- Expansion of three new plants (Karnal, Gandhidam, Mundra) aims to increase capacity, potentially enabling revenues up to INR 2,000 crore if demand picks up.
- Margins and sales are expected to improve in H2 FY26 due to strategic low-cost purchases and increased demand.
- No inventory losses reported in H1 FY26; cash-rich company can hold inventory and sell profitably when prices improve.
- Management expects growth in exports supported by recovery in global demand and new large orders, including from Saudi clients.
- The company targets to maintain profitability and integrity, with a focus on growing beyond past revenue records.
- While cautious about capacity utilization and demand volatility, overall outlook for earnings and operating profits is positive for FY26 and beyond.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- Discussions with a Saudi client are almost at a mature stage, with a complete set of orders received but some final discussions pending before shipping.
- Confidence to achieve the INR 1,500 crore revenue mark partly stems from these orders.
- Additional orders have been received from countries where previous revenue and volumes had fallen; shipments from these orders are ongoing.
- The company expects that these confirmed and incoming orders will contribute to growth in sales volumes for the remainder of the year.
